Frost Radar™: US Population Health Management, 2026

Healthcare Frost Radar™: US Population Health Management, 2026

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

INDUSTRY
Healthcare

RELEASE DATE
10-Jul-2026
REGION
North America
DELIVERABLE TYPE
Frost Radar

RESEARCH CODE
PLWW-01-00-00-00
SKU
HC_2026_34720
Yes
SHARE
$4,950.00
In stock
SKU
HC_2026_34720

Frost Radar™: US Population Health Management, 2026
Published on: 10-Jul-2026 | SKU: HC_2026_34720

Need more details?
$4,950.00
Need more details?

The population health management (PHM) market continues to benefit from provider participation in risk-based reimbursement models, including Medicare Advantage, the Medicare Shared Savings Program, and other value-based care arrangements. As organizations assume greater financial accountability, demand is increasing for platforms that can improve quality performance, optimize resource utilization, and support population-level risk management. Healthcare organizations are prioritizing solutions that translate insights into action. While analytics and risk stratification remain foundational, buyers are seeking platforms that embed care coordination, patient engagement, quality management, and performance improvement directly into clinical and operational workflows. This shift is accelerating demand for workflow-centric PHM platforms that support measurable outcomes rather than reporting alone. The availability of clinical, claims, pharmacy, and social determinants data is increasing the need for unified population health strategies. Organizations are seeking platforms that can activate disparate data sources to support longitudinal patient visibility, risk adjustment, attribution management, and financial performance improvement. Vendors that effectively connect and operationalize data across payer and provider ecosystems are strengthening their competitive position. AI adoption in PHM is expanding beyond predictive analytics into workflow automation, intervention prioritization, diagnosis gap identification, and care orchestration. Market demand is increasingly focused on practical, explainable, and workflow-integrated AI capabilities that improve productivity and support proactive population management while maintaining clinician oversight.

Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar™. The publication presents competitive profiles of each company on the Frost Radar™ considering their strengths and the opportunities that best fit those strengths.

Author: Sagar Thamaji Mukhekar

Arcadia

Athenahealth

Azara Healthcare

Cedar Gate Technologies

eClinicalWorks

Epic Systems

Evolent Health

Health Catalyst

HealthEdge Software

Innovaccer

Lightbeam Health Solutions

Medecision

NextGen Healthcare

Optum

Oracle Health

ZeOmega

Significance of Being on the Frost Radar™

CEO's Growth Team

Investors

Customers

Board of Directors

Frost Radar™: Benchmarking Future Growth Potential 2 Major Indices, 10 Analytical Ingredients, 1 Platform

Growth Index

Growth Index (GI) is a measure of a company’s growth performance and track record, along with its ability to develop and execute a fully aligned growth strategy and vision; a robust growth pipeline system; and effective market, competitor, and end-user focused sales and marketing strategies.

  • Market Share (previous 3 years)
    This is a comparison of a company’s market share relative to its competitors in a given market space for the previous 3 years.
  • Revenue Growth (previous 3 years)
    This is a look at a company’s revenue growth rate for the previous 3 years in the market/industry/category that forms the context for the given Frost Radar™.
  • Growth Pipeline
    This is an evaluation of the strength and leverage of a company’s growth pipeline system to continuously capture, analyze, and prioritize its universe of growth opportunities.
  • Vision and Strategy
    This is an assessment of how well a company’s growth strategy is aligned with its vision. Are the investments that a company is making in new products and markets consistent with the stated vision?
  • Sales and Marketing
    This is a measure of the effectiveness of a company’s sales and marketing efforts in helping it drive demand and achieve its growth objectives.

Innovation Index

Innovation Index (II) is a measure of a company’s ability to develop products/ services/ solutions (with a clear understanding of disruptive Mega Trends) that are globally applicable, are able to evolve and expand to serve multiple markets and are aligned to customers’ changing needs.

  • INNOVATION SCALABILITY
    This determines whether an organization’s innovations are globally scalable and applicable in both developing and mature markets, and also in adjacent and non-adjacent industry verticals.
  • RESEARCH AND DEVELOPMENT
    This is a measure of the efficacy of a company’s R&D strategy, as determined by the size of its R&D investment and how it feeds the innovation pipeline.
  • PRODUCT PORTFOLIO
    This is a measure of a company’s product portfolio, focusing on the relative contribution of new products to its annual revenue.
  • MEGATRENDS LEVERAGE
    This is an assessment of a company’s proactive leverage of evolving, long-term opportunities and new business models, as the foundation of its innovation pipeline.
  • CUSTOMER ALIGNMENT
    This evaluates the applicability of a company’s products/services/solutions to current and potential customers, as well as how its innovation strategy is influenced by evolving customer needs.

Significance of Being on the Frost Radar™

Companies plotted on the Frost RadarTM are the leaders in the industry for growth, innovation, or both. They are instrumental in advancing the industry into the future.

  • GROWTH POTENTIAL
    Your organization has significant future growth potential, which makes it a Company to Action.
  • BEST PRACTICES
    Your organization is well positioned to shape Growth Pipeline™ best practices in your industry.
  • COMPETITIVE INTENSITY
    Your organization is one of the key drivers of competitive intensity in the growth environment.
  • CUSTOMER VALUE
    Your organization has demonstrated the ability to significantly enhance its customer value proposition.
  • PARTNER POTENTIAL
    Your organization is top of mind for customers, investors, value chain partners, and future talent as a significant value provider.

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Digital Health research

08 Jul 2026   |   Global   |   Technology Research

Precision Obesity Management: AI-Guided Metabolic Modulation

The report explores the transformation of obesity care from generalized BMI-based treatment to AI-enabled precision metabolic management. The study highlights how obesity is increasingly recognized as a heterogeneous, multi-pathway disease influenced by genetic, neurobehavioral, metabolic, and envir...

25 Jun 2026   |   Global   |   Technology Research

Quantum Sensors Transitioning from Lab to Industry: Ultra-Precision Measurement for Healthcare, Defense, and Manufacturing

Quantum sensing is transitioning from laboratory research to industrial deployment, driven by the need for ultra-precise, reliable measurement in high-impact sectors such as healthcare, defense, and advanced manufacturing. This shift reflects a broader move from controlled, research-grade environmen...

24 Jun 2026   |   Global   |   Market Research

Top 5 Growth Opportunities in AI-Enabled Drug Discovery, 2026

As the industry continues to innovate across novel small- and large-molecule therapies, including RNA-targeted small molecules, cell and gene therapies, and mRNA therapies, pharma sponsors increasingly rely on partners for technology access, database generation and analysis, and preclinical and clin...

19 Jun 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in AI-Driven Drug Discovery, Protein Engineering, Genomic Diagnostics, Advanced Drug Delivery, and Precision Medicine

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and metabolic disorders, neuromuscular and ...

04 Jun 2026   |   Global   |   Market Outlook

Growth Opportunities in the Global Healthcare IT Industry, 2026

The Healthcare IT Outlook 2026 examines the industry’s transition from experimentation to enterprise-scale execution, as artificial intelligence (AI), workflow orchestration, and platform consolidation reshape clinical, operational, and financial workflows. Following several years of pilot-led inn...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

The population health management (PHM) market continues to benefit from provider participation in risk-based reimbursement models, including Medicare Advantage, the Medicare Shared Savings Program, and other value-based care arrangements. As organizations assume greater financial accountability, demand is increasing for platforms that can improve quality performance, optimize resource utilization, and support population-level risk management. Healthcare organizations are prioritizing solutions that translate insights into action. While analytics and risk stratification remain foundational, buyers are seeking platforms that embed care coordination, patient engagement, quality management, and performance improvement directly into clinical and operational workflows. This shift is accelerating demand for workflow-centric PHM platforms that support measurable outcomes rather than reporting alone. The availability of clinical, claims, pharmacy, and social determinants data is increasing the need for unified population health strategies. Organizations are seeking platforms that can activate disparate data sources to support longitudinal patient visibility, risk adjustment, attribution management, and financial performance improvement. Vendors that effectively connect and operationalize data across payer and provider ecosystems are strengthening their competitive position. AI adoption in PHM is expanding beyond predictive analytics into workflow automation, intervention prioritization, diagnosis gap identification, and care orchestration. Market demand is increasingly focused on practical, explainable, and workflow-integrated AI capabilities that improve productivity and support proactive population management while maintaining clinician oversight.

Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar™. The publication presents competitive profiles of each company on the Frost Radar™ considering their strengths and the opportunities that best fit those strengths.

Author: Sagar Thamaji Mukhekar
More Information
Deliverable Type Frost Radar
Industries Healthcare
No Index No
Is Prebook No
Podcast No
Predecessor KA94-01-00-00-00
WIP Number PLWW-01-00-00-00